These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 12605311)
1. Lack of relationships between cumulative methylprednisolone dose and bone mineral density in healthy men and postmenopausal women with chronic low back pain. Dubois EF; Wagemans MF; Verdouw BC; Zwinderman AH; Van Boxtel CJ; Dekhuijzen PN; Schweitzer DH Clin Rheumatol; 2003 Feb; 22(1):12-7. PubMed ID: 12605311 [TBL] [Abstract][Full Text] [Related]
2. Low bone mineral density, but not epidural steroid injection, is associated with fracture in postmenopausal women with low back pain. Yi Y; Hwang B; Son H; Cheong I Pain Physician; 2012; 15(6):441-9. PubMed ID: 23159959 [TBL] [Abstract][Full Text] [Related]
3. Changes in bone mineral density in postmenopausal women treated with epidural steroid injections for lower back pain. Kang SS; Hwang BM; Son H; Cheong IY; Lee SJ; Chung TY Pain Physician; 2012; 15(3):229-36. PubMed ID: 22622907 [TBL] [Abstract][Full Text] [Related]
4. Effects of vibration therapy on bone mineral density in postmenopausal women with osteoporosis. Ruan XY; Jin FY; Liu YL; Peng ZL; Sun YG Chin Med J (Engl); 2008 Jul; 121(13):1155-8. PubMed ID: 18710630 [TBL] [Abstract][Full Text] [Related]
5. Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study. Cooper MS; Syddall HE; Fall CH; Wood PJ; Stewart PM; Cooper C; Dennison EM Clin Endocrinol (Oxf); 2005 Jun; 62(6):692-7. PubMed ID: 15943831 [TBL] [Abstract][Full Text] [Related]
6. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Van Staa TP; Laan RF; Barton IP; Cohen S; Reid DM; Cooper C Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287 [TBL] [Abstract][Full Text] [Related]
7. Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study. Haugeberg G; Griffiths B; Sokoll KB; Emery P Ann Rheum Dis; 2004 Aug; 63(8):940-4. PubMed ID: 15249320 [TBL] [Abstract][Full Text] [Related]
8. Predicting bone mineral density of postmenopausal healthy and cirrhotic Italian women using age and body mass index. Mohamed EI; Tarantino U; Promenzio L; De Lorenzo A Acta Diabetol; 2003 Oct; 40 Suppl 1():S23-8. PubMed ID: 14618428 [TBL] [Abstract][Full Text] [Related]
9. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss]. Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543 [TBL] [Abstract][Full Text] [Related]
10. Sex steroids concentrations in relation to bone mineral density in men with coronary atherosclerosis. Dunajska K; Milewicz A; Jóźków P; Jedrzejuk D; Kuliczkowski W; Lwow F Maturitas; 2006 Sep; 55(2):142-9. PubMed ID: 16503102 [TBL] [Abstract][Full Text] [Related]
11. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory. Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z Menopause; 2009; 16(5):950-5. PubMed ID: 19387415 [TBL] [Abstract][Full Text] [Related]
12. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers. Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205 [TBL] [Abstract][Full Text] [Related]
13. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women. Arrenbrecht S; Caubel P; Garnero P; Felsenberg D Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885 [TBL] [Abstract][Full Text] [Related]
14. Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women. Sahin G; Polat G; Baethiş S; Milcan A; Baethdatoethlu O; Erdoethan C; Camdeviren H Rheumatol Int; 2003 Mar; 23(2):87-91. PubMed ID: 12634942 [TBL] [Abstract][Full Text] [Related]
15. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Malik P; Gasser RW; Kemmler G; Moncayo R; Finkenstedt G; Kurz M; Fleischhacker WW Alcohol Clin Exp Res; 2009 Feb; 33(2):375-81. PubMed ID: 19053976 [TBL] [Abstract][Full Text] [Related]
16. Association of circulating leptin with bone mineral density in males and females. Chanprasertyothin S; Piaseu N; Chailurkit L; Rajatanavin R; Ongphiphadhanakul B J Med Assoc Thai; 2005 May; 88(5):655-9. PubMed ID: 16149684 [TBL] [Abstract][Full Text] [Related]
17. Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Stepan JJ; Burr DB; Pavo I; Sipos A; Michalska D; Li J; Fahrleitner-Pammer A; Petto H; Westmore M; Michalsky D; Sato M; Dobnig H Bone; 2007 Sep; 41(3):378-85. PubMed ID: 17597017 [TBL] [Abstract][Full Text] [Related]
18. Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women. Zhong N; Wu XP; Xu ZR; Wang AH; Luo XH; Cao XZ; Xie H; Shan PF; Liao EY Clin Chim Acta; 2005 Jan; 351(1-2):161-8. PubMed ID: 15563886 [TBL] [Abstract][Full Text] [Related]
19. IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men. Rucker D; Ezzat S; Diamandi A; Khosravi J; Hanley DA Clin Endocrinol (Oxf); 2004 Apr; 60(4):491-9. PubMed ID: 15049965 [TBL] [Abstract][Full Text] [Related]
20. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments. Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]